Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

NCT00432406 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Infliximab
DRUG: Etanercept

Sponsor

Chinese University of Hong Kong